Vyzulta®

Latanoprostene Bunod 0.024%
ophthalmic solution
Antiglaucoma
[ Nitric oxide-donating prostaglandin analog]
Indication

Indication

Reduction of IOP in open-angle glaucoma or ocular hypertension
Mechanism of Action

Mechanism of Action

Increases trabecular meshwork and uveoscleral aqueous outflow. Nitric oxide increases trabecular outflow.
Common quantities available

Available Quantities

5 ml
Dosage

Dosage/Instructions

1 drop daily in the evening
Pregnancy & Nursing Data

Pregnancy & Nursing

No available human data for use during pregnancy. Causes miscarriage, abortion, and fetal harm in rabbits.
Pediatric Use

Pediatric Use

≥16 years
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Allergy to Vyzulta. Warnings: May cause a gradual change in the color of your eyes or eyelids and lashes, usually an increase in brown pigment. You may also notice increased growth or thickness of your eyelashes. These changes occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends. Common Side Effects: Conjunctival hyperemia, eye irritation, eye pain, instillation site pain, blurred vision, feeling like something is in your eye, and puffy eyelids.